Literature DB >> 16767360

Neoadjuvant S-1 and cisplatin for gastric carcinoma: there will be more to come.

Yasuhiro Kodera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767360     DOI: 10.1007/s10120-006-0376-5

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  5 in total

1.  Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination.

Authors:  Seiji Satoh; Suguru Hasegawa; Nobuhiro Ozaki; Hiroshi Okabe; Go Watanabe; Satoshi Nagayama; Masanori Fukushima; Arimichi Takabayashi; Yoshiharu Sakai
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

2.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

3.  Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

Authors:  Jaffer A Ajani; Fa-Chyi Lee; Deepti A Singh; Daniel G Haller; Heinz-Josef Lenz; Al B Benson; Ronald Yanagihara; Alexandria T Phan; James C Yao; Dirk Strumberg
Journal:  J Clin Oncol       Date:  2006-02-01       Impact factor: 44.544

4.  Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up.

Authors:  B Neri; G Cini; F Andreoli; B Boffi; D Francesconi; R Mazzanti; F Medi; A Mercatelli; S Romano; L Siliani; R Tarquini; R Moretti
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

5.  Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer.

Authors:  W Koizumi; S Tanabe; K Saigenji; A Ohtsu; N Boku; F Nagashima; K Shirao; Y Matsumura; M Gotoh
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.